Long Non-Coding RNAs as Emerging Targets in Lung Cancer
Cancers · 10.06.2023 · 15 (12) · 3135
DOI: 10.3390/cancers15123135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.06.2023. Verfasst von Jovanka Gencel-Augusto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Francisco (UCSF), San Francisco, CA 94158, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NCI, Chan-Zuckerberg Biohub, University of California President’s Post-Doctoral Fellowship.
Abstract (Originalsprache)
Long non-coding RNAs (LncRNAs) are mRNA-like molecules that do not encode for proteins and that are longer than 200 nucleotides. LncRNAs play important biological roles in normal cell physiology and organism development. Therefore, deregulation of their activities is involved in disease processes such as cancer. Lung cancer is the leading cause of cancer-related deaths due to late stage at diagnosis, distant metastasis, and high rates of therapeutic failure. LncRNAs are emerging as important molecules in lung cancer for their oncogenic or tumor-suppressive functions. LncRNAs are highly stable in circulation, presenting an opportunity for use as non-invasive and early-stage cancer diagnostic tools. Here, we summarize the latest works providing in vivo evidence available for lncRNAs role in cancer development, therapy-induced resistance, and their potential as biomarkers for diagnosis and prognosis, with a focus on lung cancer. Additionally, we discuss current therapeutic approaches to target lncRNAs. The evidence discussed here strongly suggests that investigation of lncRNAs in lung cancer in addition to protein-coding genes will provide a holistic view of molecular mechanisms of cancer initiation, development, and progression, and could open up a new avenue for cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of California San Francisco (UCSF), San Francisco, CA 94158, USA.
- UCSF Hellen Diller Comprehensive Cancer Center, San Francisco, CA 94158, USA.
- Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.
ORCID-Profile: Jovanka Gencel-Augusto, Wei Wu
Förderung
- NIH/NCI
- Chan-Zuckerberg Biohub
- University of California President’s Post-Doctoral Fellowship
Zitieren
APA
Gencel-Augusto, J., Wu, W., & Bivona, T. G. (2023). Long Non-Coding RNAs as Emerging Targets in Lung Cancer. Cancers, 15(12), 3135. https://doi.org/10.3390/cancers15123135
Vancouver
Gencel-Augusto J, Wu W, Bivona TG. Long Non-Coding RNAs as Emerging Targets in Lung Cancer. Cancers. 2023;15(12):3135. doi:10.3390/cancers15123135
BibTeX
@article{GencelAugusto2023,
author = {Gencel-Augusto, Jovanka and Wu, Wei and Bivona, Trever G},
title = {Long Non-Coding RNAs as Emerging Targets in Lung Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {12},
pages = {3135},
doi = {10.3390/cancers15123135}
}
EUVIMED